Related Experiment Video
Updated: Jul 3, 2026

Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Glutamine prevents DMBA-induced squamous cell cancer
V Lim1, S Korourian, V K Todorova
1Department of Otolaryngology, University of Arkansas for Medical Sciences (UAMS), 4301 W. Markham Street, Mail Slot 725, Little Rock, AR 72205, United States.
Abstract:
The etiology of oral squamous cell carcinoma has been linked to environmental carcinogens, such as activated aromatic heterocyclic radicals and epoxides. Our previous work on implantable and 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer showed that oral glutamine (GLN) inhibited tumor growth possibly through stimulation of host - and selective inhibition of tumor glutathione (GSH). This finding was associated with up-regulation of NK cell activity, decreased IGF-1 and TGF-beta in the circulation and downregulation of PI-3K/Akt antiapoptotic signaling in tumors. The present study was designed to investigate the effect of topically applied GLN on DMBA-induced hamster buccal pouch squamous cell carcinoma. Histopathological alterations in buccal pouches were studied by light microscopy. GLN and GSH levels in blood and buccal mucosa were determined using specific enzyme assays. The protein expression of bax, bcl-2 and PARP was determined by western blotting. H-ras and p53 genes were examined for presence of mutations using direct DNA sequencing. Fourteen weeks after DMBA application none of the GLN-supplemented animals developed tumors, while all of the control animals had well developed squamous cell carcinomas. The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and GSH, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of bcl-2. H-ras and p53 were wild type. The results from this study in combination with our previous data suggest that the chemopreventive effects of GLN are exerted by enhancing the antioxidant status of the body and activation of apoptosis.
Insights
Topical glutamine (GLN) application prevented oral cancer development in hamsters. GLN enhanced antioxidant status and promoted apoptosis, suggesting chemopreventive potential against oral squamous cell carcinoma.
Area of Science:
- Oncology
- Carcinogenesis
- Molecular Biology
Background:
- Oral squamous cell carcinoma (OSCC) etiology involves environmental carcinogens.
- Previous studies linked oral glutamine (GLN) to inhibited breast cancer growth via host stimulation and tumor glutathione (GSH) inhibition.
- GLN's effects included NK cell activity up-regulation, decreased IGF-1 and TGF-beta, and PI-3K/Akt pathway downregulation.
Purpose of the Study:
- To investigate the chemopreventive effect of topically applied glutamine (GLN) on 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch squamous cell carcinoma.
- To analyze histopathological changes, GLN and GSH levels, apoptosis-related protein expression, and gene mutations (H-ras, p53).
Main Methods:
- DMBA was applied to induce buccal pouch tumors in hamsters.
- Animals received topical GLN supplementation.
- Histopathology, enzyme assays for GLN and GSH, Western blotting for bax, bcl-2, PARP, and DNA sequencing for H-ras/p53 mutations were performed.
Main Results:
- None of the GLN-supplemented animals developed tumors, unlike all control animals.
- GLN application increased arterial GLN and GSH, and buccal mucosa GSH.
- Induction of bax and PARP, inhibition of bcl-2, and wild-type H-ras and p53 genes were observed.
Conclusions:
- Topical GLN demonstrated significant chemopreventive effects against DMBA-induced oral cancer.
- GLN's efficacy is associated with enhanced antioxidant status and apoptosis activation.
- These findings support GLN's potential as a chemopreventive agent for oral squamous cell carcinoma.
More Related Videos
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Related Concept Videos
Abnormal Proliferation
Satellite Stem Cells and Muscular Dystrophy